Teva-engineered TEV-56278 is an anti-PD1-IL2 ATTENUKINE™ therapy in Phase 1 for the treatment of various forms of cancer, including melanoma Fosun Pharma-Teva collaboration agreement established with ...
Mark Flather and Dr. Fred Brown join to expand adoption of Derisq™ and Operon™, delivering AI-powered risk prediction and portfolio optimization ...
Pete Pharma, a leader in pharmaceutical innovation and pharmaceutical IP development, is proud to announce a strategic partnership with Curexa, a nationally recognized 503A pharmacy serving a growing ...
Today, Madison, Wisconsin-based digital respiratory health company Propeller Health announced a $20 million funding round led by a $10 million investment from Aptar Pharma. Existing investors ...
GUANGZHOU, China, Jan. 16, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today ...
This partnership will enable the validation of new infectious and metabolic diagnostic tests that allow for earlier and more accurate identification of the severity of sepsis, enabling faster ...
SHANGHAI, Dec. 11, 2025 /PRNewswire/ -- OTR Therapeutics, a biotechnology company dedicated to transforming early-stage innovations into globally impactful therapies for unmet medical needs, and ...
Fortrea collaborates with Emery Pharma for rapid rifampin impurity testing in drug-drug interaction studies, enhancing participant safety and data quality. Fortrea, a global contract research ...
AC Health Pharma on Friday said that it had entered a strategic partnership with Sugi Holdings, marking the Japanese pharmacy giant’s first formal collaboration in the Philippines. Sugi Holdings, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results